AR023369A1 - Secretagogos de la hormona del crecimiento - Google Patents

Secretagogos de la hormona del crecimiento

Info

Publication number
AR023369A1
AR023369A1 ARP000100708A ARP000100708A AR023369A1 AR 023369 A1 AR023369 A1 AR 023369A1 AR P000100708 A ARP000100708 A AR P000100708A AR P000100708 A ARP000100708 A AR P000100708A AR 023369 A1 AR023369 A1 AR 023369A1
Authority
AR
Argentina
Prior art keywords
growth
secretagogos
hormone
phenyl
alkyl
Prior art date
Application number
ARP000100708A
Other languages
English (en)
Spanish (es)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of AR023369A1 publication Critical patent/AR023369A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ARP000100708A 1999-02-19 2000-02-18 Secretagogos de la hormona del crecimiento AR023369A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12081399P 1999-02-19 1999-02-19

Publications (1)

Publication Number Publication Date
AR023369A1 true AR023369A1 (es) 2002-09-04

Family

ID=22392709

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000100708A AR023369A1 (es) 1999-02-19 2000-02-18 Secretagogos de la hormona del crecimiento

Country Status (13)

Country Link
EP (1) EP1153034B1 (enExample)
JP (1) JP2002539089A (enExample)
CN (1) CN1179972C (enExample)
AR (1) AR023369A1 (enExample)
AT (1) ATE375996T1 (enExample)
AU (1) AU765642B2 (enExample)
BR (1) BR0008321A (enExample)
CA (1) CA2362303A1 (enExample)
CO (1) CO5160260A1 (enExample)
DE (1) DE60036785D1 (enExample)
IL (1) IL144350A0 (enExample)
PE (1) PE20001468A1 (enExample)
WO (1) WO2000049037A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6639076B1 (en) 1998-08-18 2003-10-28 Eli Lilly And Company Growth hormone secretagogues
US6828331B1 (en) 1999-02-19 2004-12-07 Eli Lilly And Company Growth hormone secretagogues
EP1289526A4 (en) 2000-05-30 2005-03-16 Merck & Co Inc MELANOCORTIN RECEPTOR AGONISTS
US6756385B2 (en) * 2000-07-31 2004-06-29 Pfizer Inc. Imidazole derivatives
GT200100147A (es) * 2000-07-31 2002-06-25 Derivados de imidazol
AU2001294532A1 (en) * 2000-10-13 2002-04-29 Eli Lilly And Company Resolution process for preparation of substantially pure (r) and (s) enantiomersof 2-(4-nitroimidazolyl)-4-methoxyphenylpropionic acid and salts thereof
CA2431515C (en) * 2001-01-23 2008-01-22 Gador S.A. Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition, and use thereof
US7125840B2 (en) 2001-10-09 2006-10-24 Eli Lilly And Company Substituted dipeptides as growth hormone secretagogues
AU2003220441A1 (en) 2002-04-09 2003-10-27 Eli Lilly And Company Dipeptidic growth hormone secretagogues
AP2379A (en) * 2004-03-23 2012-03-08 Pfizer Prod Inc Imidazole compounds for the treatment of neurodegenerative disorders.
EP1940802A2 (en) 2005-09-22 2008-07-09 Pfizer Products Inc. Imidazole compounds for the treatment of neurological disorders
ES3055762T3 (en) 2019-08-09 2026-02-16 Pfizer Solid state forms of (s)-2-(((s)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-n-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1h-imidazol-4-yl)pentanamide and uses thereof
US11884634B2 (en) 2019-08-09 2024-01-30 Pfizer Inc. Compositions of solid forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4- tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide
MX2024002590A (es) 2021-09-01 2024-03-22 Springworks Therapeutics Inc Sintesis de nirogacestat.
US11504354B1 (en) 2021-09-08 2022-11-22 SpringWorks Therapeutics Inc.. Chlorinated tetralin compounds and pharmaceutical compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK282166B6 (sk) * 1992-12-11 2001-11-06 Merck & Co., Inc. Spiropiperidínové deriváty, spôsob ich výroby a farmaceutický prostriedok s ich obsahom
IL107836A (en) * 1992-12-11 1998-01-04 Merck & Co Inc Spiro piperidines and homologues, their preparation and pharmaceutical preparations containing them
US5721250A (en) * 1993-12-23 1998-02-24 Merck & Co. Inc. Di-and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
JP2001502319A (ja) * 1996-10-15 2001-02-20 藤沢薬品工業株式会社 成長ホルモンの放出を促進するベンズオキセピン誘導体
ZA987383B (en) * 1997-08-19 2000-02-17 Lilly Co Eli Treatment of congestive heart failure with growth hormone secretagogues.
ZA987385B (en) * 1997-08-19 2000-04-18 Lilly Co Eli Growth hormone secretagogues.

Also Published As

Publication number Publication date
CO5160260A1 (es) 2002-05-30
CN1347420A (zh) 2002-05-01
CA2362303A1 (en) 2000-08-24
WO2000049037A1 (en) 2000-08-24
AU765642B2 (en) 2003-09-25
EP1153034A1 (en) 2001-11-14
AU3496800A (en) 2000-09-04
PE20001468A1 (es) 2000-12-20
BR0008321A (pt) 2002-01-29
IL144350A0 (en) 2002-05-23
ATE375996T1 (de) 2007-11-15
JP2002539089A (ja) 2002-11-19
DE60036785D1 (de) 2007-11-29
EP1153034B1 (en) 2007-10-17
CN1179972C (zh) 2004-12-15

Similar Documents

Publication Publication Date Title
CO4410179A1 (es) Compuestos de 1-fenil-3-dimetilamino-propano con efecto farmacologico
ATE282614T1 (de) Phenylharnstoff und phenylthioharnstoffderivate
AR048213A1 (es) 1-(4-mono-y di-halometilsulfonilfenil)-2-acilamino-fluorpropanoles analogos al florfenicol
PE20020585A1 (es) Inhibidores de metaloproteinasa del tipo pirimidin-2,4,6-triona
LU91587I2 (fr) Agomélatine et ses dérivés pharmaceutiquement acceptables (VALDOXAN)
DE69204084D1 (de) Glycyl-Serine Amide und diese enthaltende kosmetische und pharmazeutische Zusammensetzungen oder Röhrmittel.
ATE77047T1 (de) Sebosuppressive topische zubereitungen.
ES488788A0 (es) Procedimiento de preparacion de una composicion farmaceuticaen particular psicotropa.
PT892794E (pt) Prodrogas de n-hidroximetil-talidomida aciladas de efeito imunomodulador
FI894061A0 (fi) Menetelmä lääkeaineina käyttökelpoisten , -disubstituoitujen N-sykloalkyylialkyylibentsyyliamiinien valmistamiseksi ja niiden synteesivälituotteita
AR026726A1 (es) Nuevos compuestos antitromboticos y composiciones farmaceuticas que los contienen
FI812804L (fi) 2-(1,4-bensodioxan-2-ylalkyl)-imidazoler anvaendbara som antidepressiva laekemedel
CO5160260A1 (es) Secretagogos de la hormona del crecimiento derivados de imi- dazol 1,4- substituido
DK118083D0 (da) Theophyllinylalkyloxadiazoler eller additionssalte deraf, deres fremstilling og anvendelse som laegemidler
NO912298D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksanderivater.
ES8801201A1 (es) Un procedimiento para preparar derivados de pirrolidona
AR005549A1 (es) Derivados de la 1-pirazol-3-iletil-4-indol-3-ilpiperidina, un procedimiento para prepararlos, medicamentos y preparaciones farmaceuticas que los contienen,un procedimiento para preparar las preparaciones farmaceuticas y empleo de los mismos para la preparacion de medicamentos.
ES2088567T3 (es) Empleo de derivados de la 2-iminotioazolidin-4-ona como nuevos productos activos para medicamentos.
MX14537A (es) Procedimiento para la preparacion de hidroxialquil-1 nitroimidazoles y agentes de hidroxialquilacion.
ES2038159T3 (es) Procedimiento para preparar derivados sustituidos de 2-aminoacetamida.
SE8008189L (sv) Foreningar med antiallergisk och antiulceros verkan, nemligen 1-oxo-1h-tiazolo(3,2-a)pyrimidin-2-karboxamider och mellanprodukter for dessa
ATE120188T1 (de) 15-deoxyprostaglandinderivat.
ECSP003355A (es) Seretagogos de la hormona del crecimiento
ATE22289T1 (de) N-(3-trifluormethylphenyl)-n'-propargylpiperazi , seine herstellung und verwendung.
CO5040081A1 (es) Nuevos compuestos vidad farmaaceutica

Legal Events

Date Code Title Description
FB Suspension of granting procedure